Serum prolidase, urotensin-2 and nesfatin levels in patients with compensated or uncompensated cirrhosis (Annals of Medical Research, 2019;26(8):1666-1669)

Article Sidebar

PDF DOI
Published: 2024-09-26
Keywords:
None

Main Article Content

Ferzan Aydin
Harran University, Faculty of Medicine, Department of Internal Medicine, Sanliurfa, Türkiye
Cigdem Cindoglu
Harran University, Faculty of Medicine, Department of Internal Medicine, Sanliurfa, Türkiye
Idris Kirhan
Harran University, Faculty of Medicine, Department of Internal Medicine, Sanliurfa, Türkiye
Ahmet Uyanikoglu
Harran University, Faculty of Medicine, Deaprtment of Gastroenterelogy, Sanliurfa, Türkiye
Necati Yenice
Harran University, Faculty of Medicine, Deaprtment of Gastroenterelogy, Sanliurfa, Türkiye

Abstract

None

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 31 No. 9 (2024): September

Section

Erratum
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

CC Attribution-NonCommercial-NoDerivatives 4.0

How to Cite

1.
Serum prolidase, urotensin-2 and nesfatin levels in patients with compensated or uncompensated cirrhosis (Annals of Medical Research, 2019;26(8):1666-1669). Ann Med Res [Internet]. 2024 Sep. 26 [cited 2026 Apr. 19];31(9):757. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/4734

References